Great study adding to trials like the COMPASS trial and AFIRE trial.
The EPIC-CAD and AFIRE trial only included Asian patients and inter ethnic differences may exist.
Editorial by Gregory Y.H. Lip, M.D gives an insight. nejm.org/doi/full/10.10…
The EPIC-CAD and AFIRE trial only included Asian patients and inter ethnic differences may exist.
Editorial by Gregory Y.H. Lip, M.D gives an insight. nejm.org/doi/full/10.10…
The EPIC-CAD trial showed that edoxaban monotherapy was superior to edoxaban/antiplatelet therapy at preventing major adverse ischemic/bleeding events.View quoted post on X
Read the full clinical trial details here: bit.ly/3Xp77WJ #cvCAD